Overview

Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
0
Participant gender:
All
Summary
- Detection of primary antimicrobial susceptibility and resistance of Helicobacter Pylori infection. - Detection of resistance and virulence genes of Helicobacter Pylori infection. - Assessment of H pylori carcinogenicity gene. - Evaluation of outcome and efficacy of antibiotics regimen will be used in our research. - Evaluation of effect of other factors as diet (fatty and spicy meal), drugs as NSAIDs use, antibiotics for any cause on response of H pylori to antibiotics regimen.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Criteria
Inclusion Criteria:

- Any patient is above 18 years old with symptomatic H pylori infection patients diagnosed
by positive H pylori Ag in stool (naïve treatment).

Exclusion Criteria:

- Patients who aren't eligible to endoscopy.

- Patients are under 18 years old

- Patient's refusal

- history of antibiotics or proton pump inhibitor use during last month.